CAS: 83002-04-4 - 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
Formula:C24H40O3
InChI:InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m1/s1
InChI key:InChIKey=YNZFFALZMRAPHQ-SYYKKAFVSA-N
SMILES:OC1=CC(=CC=C1C2CC(O)CCC2CCCO)C(C)(C)CCCCCC
- Synonyms:
- (-)-Cp 55940
- 2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
- 5-(1,1-Dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol
- 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol
- Phenol, 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, (1α,2β,5α)-(-)-
- phenol, 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-
- phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CP-55940 REF: 7W-GL0738CAS: 83002-04-4 | - - - | To inquire | Fri 29 Nov 24 | |
(-)-CP 55940 (10 mg/mL in methanol) REF: TR-C781410CAS: 83002-04-4 | - - - | 248.00 €~2,525.00 € | Tue 07 Jan 25 | |
CP 55940 REF: 3D-FD146910CAS: 83002-04-4 | Min. 95% | To inquire | Wed 08 Jan 25 |
(-)-CP 55940 (10 mg/mL in methanol)
Controlled ProductCAS:83002-04-4
Applications CP 55,940 is a cannabinoid agonist which is considerably more potent than Δ9-THC in …
Formula:
C24H40O3
Color and Shape:
Single Solution
Molecular weight:
376.57
Ref: TR-C781410
1mg | 714.00 € | ||
5mg | 2,525.00 € | ||
250µg | 248.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
CP 55940
Controlled ProductCAS:83002-04-4
CP 55940 is a cannabinoid receptor agonist that inhibits acetylcholine release in the brain and …
Formula:
C24H40O3
Purity:
Min. 95%
Molecular weight:
376.57 g/mol
Ref: 3D-FD146910
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025